Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 707 entries
Sorted by: Best Match Show Resources per page
Preliminary results of tomotherapy for treatment of inoperable recurrent non-small cell lung cancer at bronchial stump site after right pneumonectomy.

Contemporary oncology (Poznan, Poland)

Jang HS, Moon SK.
PMID: 26199573
Contemp Oncol (Pozn). 2015;19(1):60-71. doi: 10.5114/wo.2015.48179. Epub 2015 Jan 12.

AIM OF THE STUDY: This study aimed to prospectively investigate the clinical outcomes of curative radical helical tomotherapy (HT) applied to recurrent non-small cell lung cancer (NSCLC) at the bronchial stump site after right pneumonectomy. After right pneumonectomy, the...

Cite
Jang HS, Moon SK. Preliminary results of tomotherapy for treatment of inoperable recurrent non-small cell lung cancer at bronchial stump site after right pneumonectomy. Contemp Oncol (Pozn). 2015;19(1):60-71doi: 10.5114/wo.2015.48179.
Jang, H. S., & Moon, S. K. (2015). Preliminary results of tomotherapy for treatment of inoperable recurrent non-small cell lung cancer at bronchial stump site after right pneumonectomy. Contemporary oncology (Poznan, Poland), 19(1), 60-71. https://doi.org/10.5114/wo.2015.48179
Jang, Hong Seok, and Moon, Seong Kwon. "Preliminary results of tomotherapy for treatment of inoperable recurrent non-small cell lung cancer at bronchial stump site after right pneumonectomy." Contemporary oncology (Poznan, Poland) vol. 19,1 (2015): 60-71. doi: https://doi.org/10.5114/wo.2015.48179
Jang HS, Moon SK. Preliminary results of tomotherapy for treatment of inoperable recurrent non-small cell lung cancer at bronchial stump site after right pneumonectomy. Contemp Oncol (Pozn). 2015;19(1):60-71. doi: 10.5114/wo.2015.48179. Epub 2015 Jan 12. PMID: 26199573; PMCID: PMC4507888.
Copy Download .nbib Format: NLM
Paraneoplastic syndromes in olfactory neuroblastoma.

Contemporary oncology (Poznan, Poland)

Kunc M, Gabrych A, Czapiewski P, Sworczak K.
PMID: 26199564
Contemp Oncol (Pozn). 2015;19(1):6-16. doi: 10.5114/wo.2015.46283. Epub 2015 Mar 26.

Olfactory neuroblastoma (ONB) is a rare malignant neoplasm of sinonasal tract, derived from olfactory epithelium. Unilateral nasal obstruction, epistaxis, sinusitis, and headaches are common symptoms. Olfactory neuroblastoma shows neuroendocrine differentiation and similarly to other neuroendocrine tumors can produce several...

Cite
Kunc M, Gabrych A, Czapiewski P, et al. Paraneoplastic syndromes in olfactory neuroblastoma. Contemp Oncol (Pozn). 2015;19(1):6-16doi: 10.5114/wo.2015.46283.
Kunc, M., Gabrych, A., Czapiewski, P., & Sworczak, K. (2015). Paraneoplastic syndromes in olfactory neuroblastoma. Contemporary oncology (Poznan, Poland), 19(1), 6-16. https://doi.org/10.5114/wo.2015.46283
Kunc, Michał, et al. "Paraneoplastic syndromes in olfactory neuroblastoma." Contemporary oncology (Poznan, Poland) vol. 19,1 (2015): 6-16. doi: https://doi.org/10.5114/wo.2015.46283
Kunc M, Gabrych A, Czapiewski P, Sworczak K. Paraneoplastic syndromes in olfactory neuroblastoma. Contemp Oncol (Pozn). 2015;19(1):6-16. doi: 10.5114/wo.2015.46283. Epub 2015 Mar 26. PMID: 26199564; PMCID: PMC4507891.
Copy Download .nbib Format: NLM
P27 expression in pleomorphic salivary gland adenoma.

Contemporary oncology (Poznan, Poland)

Tarakji B, Umair A, Altamimi MA, Azzeghaiby SN, Mahmoud AS, Darwish S, Nassani MZ, Ashok N.
PMID: 26199567
Contemp Oncol (Pozn). 2015;19(1):28-31. doi: 10.5114/wo.2014.45294. Epub 2014 Sep 23.

AIM OF THE STUDY: This study aims to characterise alterations in the immunohistochemical expression of p27 in normal tissue of the salivary gland surrounding pleomorphic adenoma and in the tumour cells of pleomorphic adenoma.MATERIAL AND METHODS: A retrospective study...

Cite
Tarakji B, Umair A, Altamimi MA, et al. P27 expression in pleomorphic salivary gland adenoma. Contemp Oncol (Pozn). 2014;19(1):28-31doi: 10.5114/wo.2014.45294.
Tarakji, B., Umair, A., Altamimi, M. A., Azzeghaiby, S. N., Mahmoud, A. S., Darwish, S., Nassani, M. Z., & Ashok, N. (2015). P27 expression in pleomorphic salivary gland adenoma. Contemporary oncology (Poznan, Poland), 19(1), 28-31. https://doi.org/10.5114/wo.2014.45294
Tarakji, Bassel, et al. "P27 expression in pleomorphic salivary gland adenoma." Contemporary oncology (Poznan, Poland) vol. 19,1 (2015): 28-31. doi: https://doi.org/10.5114/wo.2014.45294
Tarakji B, Umair A, Altamimi MA, Azzeghaiby SN, Mahmoud AS, Darwish S, Nassani MZ, Ashok N. P27 expression in pleomorphic salivary gland adenoma. Contemp Oncol (Pozn). 2015;19(1):28-31. doi: 10.5114/wo.2014.45294. Epub 2014 Sep 23. PMID: 26199567; PMCID: PMC4507890.
Copy Download .nbib Format: NLM
The use of Yttrium-90 Ibritumomab Tiuxetan ((90)Y-IT) as a consolidation therapy in high-risk patients with diffuse large B-cell lymphoma ineligible for autologous stem-cell transplantation.

Contemporary oncology (Poznan, Poland)

Jurczak W, Kisiel E, Sawczuk-Chabin J, Centkowski P, Knopińska-Posłuszny W, Khan O.
PMID: 26199570
Contemp Oncol (Pozn). 2015;19(1):43-7. doi: 10.5114/wo.2015.50012. Epub 2015 Mar 26.

AIM OF THE STUDY: To evaluate the efficacy and safety of Yttrium-90 Ibritumomab Tiuxetan ((90)Y-IT) as a consolidation therapy in the management of DLBCL.MATERIAL AND METHODS: Patients with primary refractory or high-risk DLBCL (n = 18), ineligible for autologous...

Cite
Jurczak W, Kisiel E, Sawczuk-Chabin J, et al. The use of Yttrium-90 Ibritumomab Tiuxetan ((90)Y-IT) as a consolidation therapy in high-risk patients with diffuse large B-cell lymphoma ineligible for autologous stem-cell transplantation. Contemp Oncol (Pozn). 2015;19(1):43-7doi: 10.5114/wo.2015.50012.
Jurczak, W., Kisiel, E., Sawczuk-Chabin, J., Centkowski, P., Knopińska-Posłuszny, W., & Khan, O. (2015). The use of Yttrium-90 Ibritumomab Tiuxetan ((90)Y-IT) as a consolidation therapy in high-risk patients with diffuse large B-cell lymphoma ineligible for autologous stem-cell transplantation. Contemporary oncology (Poznan, Poland), 19(1), 43-7. https://doi.org/10.5114/wo.2015.50012
Jurczak, Wojciech, et al. "The use of Yttrium-90 Ibritumomab Tiuxetan ((90)Y-IT) as a consolidation therapy in high-risk patients with diffuse large B-cell lymphoma ineligible for autologous stem-cell transplantation." Contemporary oncology (Poznan, Poland) vol. 19,1 (2015): 43-7. doi: https://doi.org/10.5114/wo.2015.50012
Jurczak W, Kisiel E, Sawczuk-Chabin J, Centkowski P, Knopińska-Posłuszny W, Khan O. The use of Yttrium-90 Ibritumomab Tiuxetan ((90)Y-IT) as a consolidation therapy in high-risk patients with diffuse large B-cell lymphoma ineligible for autologous stem-cell transplantation. Contemp Oncol (Pozn). 2015;19(1):43-7. doi: 10.5114/wo.2015.50012. Epub 2015 Mar 26. PMID: 26199570; PMCID: PMC4507887.
Copy Download .nbib Format: NLM
The prognostic significance of tumor epidermal growth factor receptor (EGFR) expression change after neoadjuvant chemoradiation in patients with rectal adenocarcinoma.

Contemporary oncology (Poznan, Poland)

Richter I, Dvořák J, Urbanec M, Bluml A, Čermáková E, Bartoš J, Petera J.
PMID: 26199571
Contemp Oncol (Pozn). 2015;19(1):48-53. doi: 10.5114/wo.2015.50013. Epub 2015 Mar 26.

AIM OF THE STUDY: The aim of this retrospective study was to determine the prognostic impact of epidermal growth factor receptor (EGFR) expression changes during neoadjuvant chemoradiotherapy in patients with locally advanced rectal cancer.MATERIAL AND METHODS: Fifty patients with...

Cite
Richter I, Dvořák J, Urbanec M, et al. The prognostic significance of tumor epidermal growth factor receptor (EGFR) expression change after neoadjuvant chemoradiation in patients with rectal adenocarcinoma. Contemp Oncol (Pozn). 2015;19(1):48-53doi: 10.5114/wo.2015.50013.
Richter, I., Dvořák, J., Urbanec, M., Bluml, A., Čermáková, E., Bartoš, J., & Petera, J. (2015). The prognostic significance of tumor epidermal growth factor receptor (EGFR) expression change after neoadjuvant chemoradiation in patients with rectal adenocarcinoma. Contemporary oncology (Poznan, Poland), 19(1), 48-53. https://doi.org/10.5114/wo.2015.50013
Richter, Igor, et al. "The prognostic significance of tumor epidermal growth factor receptor (EGFR) expression change after neoadjuvant chemoradiation in patients with rectal adenocarcinoma." Contemporary oncology (Poznan, Poland) vol. 19,1 (2015): 48-53. doi: https://doi.org/10.5114/wo.2015.50013
Richter I, Dvořák J, Urbanec M, Bluml A, Čermáková E, Bartoš J, Petera J. The prognostic significance of tumor epidermal growth factor receptor (EGFR) expression change after neoadjuvant chemoradiation in patients with rectal adenocarcinoma. Contemp Oncol (Pozn). 2015;19(1):48-53. doi: 10.5114/wo.2015.50013. Epub 2015 Mar 26. PMID: 26199571; PMCID: PMC4507892.
Copy Download .nbib Format: NLM
Diagnostic methods for detection of bone metastases.

Contemporary oncology (Poznan, Poland)

Łukaszewski B, Nazar J, Goch M, Łukaszewska M, Stępiński A, Jurczyk MU.
PMID: 28947878
Contemp Oncol (Pozn). 2017;21(2):98-103. doi: 10.5114/wo.2017.68617. Epub 2017 Jun 30.

Skeletal metastases are severe complications in the course of cancer, and they indicate a worse prognosis. The use of modern imaging techniques allows rapid diagnosis of bone metastases. Properly selected diagnostic imaging (scintigraphy, positron emission tomography, whole body MRI)...

Cite
Łukaszewski B, Nazar J, Goch M, et al. Diagnostic methods for detection of bone metastases. Contemp Oncol (Pozn). 2017;21(2):98-103doi: 10.5114/wo.2017.68617.
Łukaszewski, B., Nazar, J., Goch, M., Łukaszewska, M., Stępiński, A., & Jurczyk, M. U. (2017). Diagnostic methods for detection of bone metastases. Contemporary oncology (Poznan, Poland), 21(2), 98-103. https://doi.org/10.5114/wo.2017.68617
Łukaszewski, Bartosz, et al. "Diagnostic methods for detection of bone metastases." Contemporary oncology (Poznan, Poland) vol. 21,2 (2017): 98-103. doi: https://doi.org/10.5114/wo.2017.68617
Łukaszewski B, Nazar J, Goch M, Łukaszewska M, Stępiński A, Jurczyk MU. Diagnostic methods for detection of bone metastases. Contemp Oncol (Pozn). 2017;21(2):98-103. doi: 10.5114/wo.2017.68617. Epub 2017 Jun 30. PMID: 28947878; PMCID: PMC5611498.
Copy Download .nbib Format: NLM
Crosstalk between mesenchymal stem cells and macrophages in inflammatory bowel disease and associated colorectal cancer.

Contemporary oncology (Poznan, Poland)

Mao F, Kang JJ, Cai X, Ding NF, Wu YB, Yan YM, Qian H, Zhang X, Xu WR.
PMID: 28947877
Contemp Oncol (Pozn). 2017;21(2):91-97. doi: 10.5114/wo.2017.68616. Epub 2017 Jun 30.

Mesenchymal stem cells (MSCs) are attractive seed cells for immunotherapy, tissue engineering and regenerative medicine due to their self-renewal and multidirectional differentiation abilities, diverse immunoregulatory functions and ease of isolation from a wide range of tissues. MSCs exert their...

Cite
Mao F, Kang JJ, Cai X, et al. Crosstalk between mesenchymal stem cells and macrophages in inflammatory bowel disease and associated colorectal cancer. Contemp Oncol (Pozn). 2017;21(2):91-97doi: 10.5114/wo.2017.68616.
Mao, F., Kang, J. J., Cai, X., Ding, N. F., Wu, Y. B., Yan, Y. M., Qian, H., Zhang, X., & Xu, W. R. (2017). Crosstalk between mesenchymal stem cells and macrophages in inflammatory bowel disease and associated colorectal cancer. Contemporary oncology (Poznan, Poland), 21(2), 91-97. https://doi.org/10.5114/wo.2017.68616
Mao, Fei, et al. "Crosstalk between mesenchymal stem cells and macrophages in inflammatory bowel disease and associated colorectal cancer." Contemporary oncology (Poznan, Poland) vol. 21,2 (2017): 91-97. doi: https://doi.org/10.5114/wo.2017.68616
Mao F, Kang JJ, Cai X, Ding NF, Wu YB, Yan YM, Qian H, Zhang X, Xu WR. Crosstalk between mesenchymal stem cells and macrophages in inflammatory bowel disease and associated colorectal cancer. Contemp Oncol (Pozn). 2017;21(2):91-97. doi: 10.5114/wo.2017.68616. Epub 2017 Jun 30. PMID: 28947877; PMCID: PMC5611497.
Copy Download .nbib Format: NLM
The safety of low-molecular-weight heparins in the prevention of venous thromboembolism in surgically-treated cancer patients: results of a multicentre observational study.

Contemporary oncology (Poznan, Poland)

Olesiński T, Fijałkowska A, Rutkowski A.
PMID: 28947885
Contemp Oncol (Pozn). 2017;21(2):152-156. doi: 10.5114/wo.2017.68624. Epub 2017 Jun 30.

AIM OF THE STUDY: Despite widespread use of pharmacological prophylaxis, venous thromboembolism (VTE) still constitutes a common complication in cancer patients. The aim of the study was to analyse the safety of low-molecular-weight heparins (LMWH) in the prevention of...

Cite
Olesiński T, Fijałkowska A, Rutkowski A. The safety of low-molecular-weight heparins in the prevention of venous thromboembolism in surgically-treated cancer patients: results of a multicentre observational study. Contemp Oncol (Pozn). 2017;21(2):152-156doi: 10.5114/wo.2017.68624.
Olesiński, T., Fijałkowska, A., & Rutkowski, A. (2017). The safety of low-molecular-weight heparins in the prevention of venous thromboembolism in surgically-treated cancer patients: results of a multicentre observational study. Contemporary oncology (Poznan, Poland), 21(2), 152-156. https://doi.org/10.5114/wo.2017.68624
Olesiński, Tomasz, et al. "The safety of low-molecular-weight heparins in the prevention of venous thromboembolism in surgically-treated cancer patients: results of a multicentre observational study." Contemporary oncology (Poznan, Poland) vol. 21,2 (2017): 152-156. doi: https://doi.org/10.5114/wo.2017.68624
Olesiński T, Fijałkowska A, Rutkowski A. The safety of low-molecular-weight heparins in the prevention of venous thromboembolism in surgically-treated cancer patients: results of a multicentre observational study. Contemp Oncol (Pozn). 2017;21(2):152-156. doi: 10.5114/wo.2017.68624. Epub 2017 Jun 30. PMID: 28947885; PMCID: PMC5611505.
Copy Download .nbib Format: NLM
Radiotherapy and anthracyclines - cardiovascular toxicity.

Contemporary oncology (Poznan, Poland)

Mozdzanowska D, Woźniewski M.
PMID: 26034385
Contemp Oncol (Pozn). 2015;19(2):93-7. doi: 10.5114/wo.2014.40108. Epub 2014 Jun 24.

The subject of this paper is to analyze the impact of radiotherapy and anthracyclines on the cardiovascular system, based on a survey of contemporary literature. Currently, high efficiency of anticancer therapies has increased the rate of survival in patients...

Cite
Mozdzanowska D, Woźniewski M. Radiotherapy and anthracyclines - cardiovascular toxicity. Contemp Oncol (Pozn). 2014;19(2):93-7doi: 10.5114/wo.2014.40108.
Mozdzanowska, D., & Woźniewski, M. (2015). Radiotherapy and anthracyclines - cardiovascular toxicity. Contemporary oncology (Poznan, Poland), 19(2), 93-7. https://doi.org/10.5114/wo.2014.40108
Mozdzanowska, Dagmara, and Woźniewski, Marek. "Radiotherapy and anthracyclines - cardiovascular toxicity." Contemporary oncology (Poznan, Poland) vol. 19,2 (2015): 93-7. doi: https://doi.org/10.5114/wo.2014.40108
Mozdzanowska D, Woźniewski M. Radiotherapy and anthracyclines - cardiovascular toxicity. Contemp Oncol (Pozn). 2015;19(2):93-7. doi: 10.5114/wo.2014.40108. Epub 2014 Jun 24. PMID: 26034385; PMCID: PMC4444437.
Copy Download .nbib Format: NLM
Association between breast cancer and tumour necrosis factor-related apoptosis-inducing ligand (TRAIL) gene 1595C/T SNP in a Pakistani population.

Contemporary oncology (Poznan, Poland)

Rehman SF, Mansoor Q, Farooqi AA, Nazir N, Kausar R, Jabeen N, Ismail M.
PMID: 27358600
Contemp Oncol (Pozn). 2016;20(2):185-7. doi: 10.5114/wo.2015.55421. Epub 2015 Dec 08.

AIM OF THE STUDY: TRAIL-mediated signalling has emerged as an extensively studied biological mechanism reported to differentially induce apoptosis in cancer cells. However, overwhelmingly increasing experimentally verified data is shedding light on resistance against TRAIL-induced apoptosis in cancer cells....

Cite
Rehman SF, Mansoor Q, Farooqi AA, et al. Association between breast cancer and tumour necrosis factor-related apoptosis-inducing ligand (TRAIL) gene 1595C/T SNP in a Pakistani population. Contemp Oncol (Pozn). 2015;20(2):185-7doi: 10.5114/wo.2015.55421.
Rehman, S. F., Mansoor, Q., Farooqi, A. A., Nazir, N., Kausar, R., Jabeen, N., & Ismail, M. (2016). Association between breast cancer and tumour necrosis factor-related apoptosis-inducing ligand (TRAIL) gene 1595C/T SNP in a Pakistani population. Contemporary oncology (Poznan, Poland), 20(2), 185-7. https://doi.org/10.5114/wo.2015.55421
Rehman, Saima F, et al. "Association between breast cancer and tumour necrosis factor-related apoptosis-inducing ligand (TRAIL) gene 1595C/T SNP in a Pakistani population." Contemporary oncology (Poznan, Poland) vol. 20,2 (2016): 185-7. doi: https://doi.org/10.5114/wo.2015.55421
Rehman SF, Mansoor Q, Farooqi AA, Nazir N, Kausar R, Jabeen N, Ismail M. Association between breast cancer and tumour necrosis factor-related apoptosis-inducing ligand (TRAIL) gene 1595C/T SNP in a Pakistani population. Contemp Oncol (Pozn). 2016;20(2):185-7. doi: 10.5114/wo.2015.55421. Epub 2015 Dec 08. PMID: 27358600; PMCID: PMC4925726.
Copy Download .nbib Format: NLM
The effect of tumor volume on radiotherapy outcome and correlation with other prognostic factors in patients with T2 supraglottic cancer.

Contemporary oncology (Poznan, Poland)

Rutkowski TW, Maciejewski B, Kołosza Z, Wygoda A, Składowski K, Hejduk B, Rutkowski R.
PMID: 25784843
Contemp Oncol (Pozn). 2014;18(6):429-35. doi: 10.5114/wo.2014.44542. Epub 2014 Dec 31.

The retrospective chart review of 110 patients with T2 supraglottic cancer who underwent radiotherapy was performed to correlate tumor volume with other prognostic factors and to analyze its impact on treatment results. Patients with involved nodes, poor histopathological tumor...

Cite
Rutkowski TW, Maciejewski B, Kołosza Z, et al. The effect of tumor volume on radiotherapy outcome and correlation with other prognostic factors in patients with T2 supraglottic cancer. Contemp Oncol (Pozn). 2014;18(6):429-35doi: 10.5114/wo.2014.44542.
Rutkowski, T. W., Maciejewski, B., Kołosza, Z., Wygoda, A., Składowski, K., Hejduk, B., & Rutkowski, R. (2014). The effect of tumor volume on radiotherapy outcome and correlation with other prognostic factors in patients with T2 supraglottic cancer. Contemporary oncology (Poznan, Poland), 18(6), 429-35. https://doi.org/10.5114/wo.2014.44542
Rutkowski, Tomasz W, et al. "The effect of tumor volume on radiotherapy outcome and correlation with other prognostic factors in patients with T2 supraglottic cancer." Contemporary oncology (Poznan, Poland) vol. 18,6 (2014): 429-35. doi: https://doi.org/10.5114/wo.2014.44542
Rutkowski TW, Maciejewski B, Kołosza Z, Wygoda A, Składowski K, Hejduk B, Rutkowski R. The effect of tumor volume on radiotherapy outcome and correlation with other prognostic factors in patients with T2 supraglottic cancer. Contemp Oncol (Pozn). 2014;18(6):429-35. doi: 10.5114/wo.2014.44542. Epub 2014 Dec 31. PMID: 25784843; PMCID: PMC4355652.
Copy Download .nbib Format: NLM
The association of subtypes of breast cancer with tumour characteristics and reproductive factors in 1326 Mexican women.

Contemporary oncology (Poznan, Poland)

Pérez-Rodríguez G, Aranda-Moreno C, Olivares-Corichi IM, Garcia-Sanchez JR.
PMID: 26843843
Contemp Oncol (Pozn). 2015;19(6):462-6. doi: 10.5114/wo.2015.56652. Epub 2016 Jan 13.

AIM OF THE STUDY: In breast cancer, oestrogen receptor (ER), progesterone receptor (PgR), and HER2 (HER2/Neu) expression status are used to classify neoplasms into subtypes: Luminal A, Luminal B, HER2/Neu type, and Basallike. The aim of the present study...

Cite
Pérez-Rodríguez G, Aranda-Moreno C, Olivares-Corichi IM, et al. The association of subtypes of breast cancer with tumour characteristics and reproductive factors in 1326 Mexican women. Contemp Oncol (Pozn). 2016;19(6):462-6doi: 10.5114/wo.2015.56652.
Pérez-Rodríguez, G., Aranda-Moreno, C., Olivares-Corichi, I. M., & Garcia-Sanchez, J. R. (2015). The association of subtypes of breast cancer with tumour characteristics and reproductive factors in 1326 Mexican women. Contemporary oncology (Poznan, Poland), 19(6), 462-6. https://doi.org/10.5114/wo.2015.56652
Pérez-Rodríguez, Gabriel, et al. "The association of subtypes of breast cancer with tumour characteristics and reproductive factors in 1326 Mexican women." Contemporary oncology (Poznan, Poland) vol. 19,6 (2015): 462-6. doi: https://doi.org/10.5114/wo.2015.56652
Pérez-Rodríguez G, Aranda-Moreno C, Olivares-Corichi IM, Garcia-Sanchez JR. The association of subtypes of breast cancer with tumour characteristics and reproductive factors in 1326 Mexican women. Contemp Oncol (Pozn). 2015;19(6):462-6. doi: 10.5114/wo.2015.56652. Epub 2016 Jan 13. PMID: 26843843; PMCID: PMC4731452.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 707 entries